| scholarly article | Q13442814 |
| P50 | author | Nita H. Salzman | Q42568978 |
| Talal A Chatila | Q60539789 | ||
| Dipica Haribhai | Q124216890 | ||
| Jennifer Ziegelbauer | Q124216891 | ||
| P2093 | author name string | Wen Lin | |
| Pippa M Simpson | |||
| Calvin B Williams | |||
| Shun-Hwa Li | |||
| Brandon Edwards | |||
| Marc R Carlson | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice | Q24293865 | ||
| Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 | ||
| Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin | Q24605629 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development | Q28266281 | ||
| Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors | Q28268827 | ||
| Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor | Q28273769 | ||
| Where CD4+CD25+ T reg cells impinge on autoimmune diabetes | Q28506933 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires | Q28590409 | ||
| Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
| Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor | Q28593665 | ||
| A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 | ||
| Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid | Q29615586 | ||
| Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Epigenetic control of the foxp3 locus in regulatory T cells | Q33273617 | ||
| Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 | ||
| Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice | Q34321778 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells | Q34556464 | ||
| Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms | Q34570917 | ||
| Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells | Q34577919 | ||
| Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes | Q34660281 | ||
| Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. | Q35773643 | ||
| TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets | Q36229637 | ||
| Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen | Q36403106 | ||
| Developmental regulation of Foxp3 expression during ontogeny. | Q36403564 | ||
| Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation | Q36563545 | ||
| Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. | Q36891917 | ||
| Ligand-independent regulation of transforming growth factor beta1 expression and cell cycle progression by the aryl hydrocarbon receptor. | Q38300363 | ||
| Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells | Q42114183 | ||
| Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. | Q42844822 | ||
| Regulatory T cell development in the absence of functional Foxp3. | Q44440268 | ||
| IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells | Q46040716 | ||
| DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. | Q52924279 | ||
| Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. | Q54597061 | ||
| Foxp3-dependent programme of regulatory T-cell differentiation | Q59084714 | ||
| Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature | Q61713917 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| Regulatory T cells dynamically control the primary immune response to foreign antigen | Q79803360 | ||
| Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells | Q80034250 | ||
| Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors | Q80444910 | ||
| CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion | Q81111400 | ||
| Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3461-3468 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | A central role for induced regulatory T cells in tolerance induction in experimental colitis | |
| P478 | volume | 182 |
| Q55362406 | A Context-Dependent Role for αv Integrins in Regulatory T Cell Accumulation at Sites of Inflammation. |
| Q62040086 | A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2 |
| Q34420793 | A peripheral CD4+ T cell precursor for naive, memory, and regulatory T cells |
| Q24622687 | A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity |
| Q39329596 | Adoptive T cell therapy: An overview of obstacles and opportunities. |
| Q42146204 | Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis. |
| Q36853641 | Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis |
| Q48155143 | Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases. |
| Q38648169 | Antigen-specific regulatory T-cell responses to intestinal microbiota |
| Q92647638 | Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation |
| Q37599020 | CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype |
| Q37599576 | CD28- and CD28lowCD8+ Regulatory T Cells: Of Mice and Men |
| Q37076943 | CD4(+) T-cell subsets in intestinal inflammation |
| Q35155979 | CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment? |
| Q36055096 | CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity |
| Q39279238 | Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells |
| Q26853475 | Cellular and molecular determinants for the development of natural and induced regulatory T cells |
| Q35843507 | Challenges and future perspectives of T cell immunotherapy in cancer |
| Q37486824 | Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression |
| Q35926395 | Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate |
| Q100960448 | Comprehensive phenotyping of peripheral blood T lymphocytes in healthy mice |
| Q36457068 | Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions |
| Q37200597 | Contribution of Mesenteric Lymph Nodes and GALT to the Intestinal Foxp3+ Regulatory T-Cell Compartment. |
| Q42571627 | Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancer |
| Q39096604 | Critical influence of the thymus on peripheral T cell homeostasis |
| Q38924558 | Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans |
| Q47149234 | Cyclic AMP-Responsive Element-Binding Protein (CREB) is Critical in Autoimmunity by Promoting Th17 but Inhibiting Treg Cell Differentiation |
| Q39376990 | Cytokine Signaling in the Development and Homeostasis of Regulatory T cells |
| Q35156962 | Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1. |
| Q39415789 | Distinct modes of antigen presentation promote the formation, differentiation, and activity of foxp3+ regulatory T cells in vivo |
| Q52595030 | Dynamics of peripheral tolerance and immune regulation mediated by Treg. |
| Q46341919 | Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole. |
| Q37049828 | Enlarged colitogenic T cell population paradoxically supports colitis prevention through the B-lymphocyte-dependent peripheral generation of CD4(+)Foxp3(+) Treg cells |
| Q54942553 | Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review. |
| Q37857437 | Experimental inflammatory bowel disease: insights into the host-microbiota dialog |
| Q45730470 | Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner. |
| Q37634024 | Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease |
| Q60483615 | FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS |
| Q36305999 | Foxp3 expression is required for the induction of therapeutic tissue tolerance |
| Q40606910 | Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation |
| Q40509547 | Foxp3(+) regulatory T cells in mouse models of type 1 diabetes |
| Q37523266 | Foxp3+ regulatory T cells: differentiation, specification, subphenotypes |
| Q39018591 | Foxp3, Regulatory T Cell, and Autoimmune Diseases |
| Q37407658 | Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset |
| Q52584033 | Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis. |
| Q36938160 | Generation and function of induced regulatory T cells |
| Q33778238 | Genomic definition of multiple ex vivo regulatory T cell subphenotypes |
| Q39640911 | Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells. |
| Q39036180 | Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes |
| Q35624877 | Harnessing regulatory T cells for the treatment of inflammatory bowel disease. |
| Q36019528 | Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis. |
| Q38881545 | Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β. |
| Q36509935 | IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy |
| Q58271921 | IL2 is required for functional maturation of regulatory T cells |
| Q35110225 | Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis |
| Q56891548 | Immune quiescence in the oral mucosa is maintained by a uniquely large population of highly activated Foxp3 regulatory T cells |
| Q61805064 | Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity |
| Q51727790 | Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease. |
| Q37529334 | Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection |
| Q51212581 | In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol. |
| Q36948341 | Induced and natural regulatory T cells in the development of inflammatory bowel disease |
| Q54678222 | Induced and thymus-derived Foxp3⁺ regulatory T cells share a common niche. |
| Q38577707 | Induction of Immune Tolerance to Dietary Antigens |
| Q33954755 | Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells |
| Q60959788 | Inhibins regulate peripheral regulatory T cell induction through modulation of dendritic cell function |
| Q35053246 | Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease |
| Q35714248 | Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis |
| Q33737660 | Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells |
| Q37350865 | Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs |
| Q92001013 | Large-Scale Generation of Human Allospecific Induced Tregs With Functional Stability for Use in Immunotherapy in Transplantation |
| Q41677301 | Liver X receptor activation promotes differentiation of regulatory T cells |
| Q35877614 | MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. |
| Q38130307 | Microbial activation of gut dendritic cells and the control of mucosal immunity |
| Q33988531 | Mining the human gut microbiota for effector strains that shape the immune system |
| Q39961439 | Mouse and human CD8(+) CD28(low) regulatory T lymphocytes differentiate in the thymus. |
| Q35984305 | MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism |
| Q38123165 | Natural and induced T regulatory cells in cancer. |
| Q36278051 | Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells |
| Q42786561 | Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer |
| Q50996951 | On the road to tolerance--generation and migration of gut regulatory T cells. |
| Q37076945 | Peripherally induced tregs - role in immune homeostasis and autoimmunity |
| Q33740542 | Peroxisome Proliferator-Activated Receptor α and γ Agonists Together with TGF-β Convert Human CD4+CD25− T Cells into Functional Foxp3+ Regulatory T Cells |
| Q35863212 | Phenotypic and functional properties of Helios+ regulatory T cells |
| Q36890286 | Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability |
| Q41811764 | Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms |
| Q41882539 | Rapid and unambiguous detection of DNase I hypersensitive site in rare population of cells |
| Q36781877 | Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery |
| Q53543423 | Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs. |
| Q37951621 | Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins |
| Q36713986 | Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2 |
| Q38165191 | Regulation of antiviral CD8 T-cell responses |
| Q90573900 | Regulatory T Cell Development in the Thymus |
| Q27691329 | Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features |
| Q33715605 | Regulatory T Cells in Allergy and Asthma. |
| Q91740503 | Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection |
| Q35196374 | Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy |
| Q34789108 | Regulatory T cells and immune tolerance in the intestine |
| Q41834768 | Regulatory T cells and the control of the allergic response. |
| Q38946820 | Regulatory T cells in allergic diseases. |
| Q38139203 | Regulatory T cells in nonlymphoid tissues |
| Q42115384 | Regulatory T cells in radiotherapeutic responses |
| Q34743118 | Requirements for growth and IL-10 expression of highly purified human T regulatory cells |
| Q37916797 | Retinoic acid generates regulatory T cells in experimental transplantation |
| Q37809744 | Shaping the T-cell repertoire in the periphery |
| Q38996948 | Skin-derived TSLP systemically expands regulatory T cells |
| Q58412544 | Sox12 promotes T reg differentiation in the periphery during colitis |
| Q92802893 | T cell-mediated immunity to malaria |
| Q35836118 | T cells in the control of organ-specific autoimmunity |
| Q36093770 | T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis |
| Q26862699 | T-regulatory cells in primary immune deficiencies |
| Q89209907 | TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice |
| Q45352269 | TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway |
| Q39471157 | Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus |
| Q33894387 | Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity |
| Q60956635 | The Role of Histone Methyltransferases and Long Non-coding RNAs in the Regulation of T Cell Fate Decisions |
| Q34217756 | The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. |
| Q50794921 | The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells. |
| Q37531844 | The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients |
| Q43535267 | The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages |
| Q38080948 | The life of regulatory T cells |
| Q60651239 | The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization |
| Q38117369 | The role of regulatory T cells in the biology of graft versus host disease. |
| Q58115470 | The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells |
| Q37265675 | Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation. |
| Q57792513 | Thymus-derived Foxp3 regulatory T cells upregulate RORγt expression under inflammatory conditions |
| Q34318874 | Trafficking of regulatory T cells in the intestinal immune system |
| Q85329437 | Transient Treg-cell depletion in adult mice results in persistent self-reactive CD4(+) T-cell responses |
| Q36192911 | Treg cells, life history, and diversity |
| Q87917259 | Type 3 regulatory T cells at the interface of symbiosis |
| Q37495438 | Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis. |
| Q37231889 | Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis. |
| Q31081160 | Vagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells |
| Q41517533 | Vagotomy affects the development of oral tolerance and increases susceptibility to develop colitis independently of the alpha-7 nicotinic receptor |
| Q52909789 | What makes children outgrow food allergy? |
Search more.